Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:51:33 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



Z:BHC - BAUSCH HEALTH COMPANIES INC - https://www.bauschhealth.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BHC - Z0.17.20·7.900.17.82-0.28-3.53,396.626,3937,2708.10  8.23  7.7411.46  5.570319:45:54May 0215 min RT 2¢

Recent Trades - Last 10 of 7270
Time ETExPriceChangeVolume
19:45:54Z7.90-0.191
19:45:35Z7.90-0.1950
19:29:23Z7.90-0.1975
19:07:16Z7.90-0.1950
17:56:25Z7.90-0.195,000
17:30:09Z8.150.061
17:30:08Z8.200.111
17:28:48Z7.87-0.221,400
16:53:20Z8.110.021
16:53:20Z8.110.021

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-02 07:03U:BHCNews ReleaseBausch Health Announces First Quarter 2024 Results
2024-04-11 16:23U:BHCNews ReleaseBausch Health to Announce First-Quarter 2024 Results on May 2
2024-04-11 13:06U:BHCNews ReleaseCourt of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
2024-04-11 08:02U:BHCNews ReleaseAcne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
2024-04-05 18:16U:BHCNews ReleaseBausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
2024-04-03 08:03U:BHCNews ReleaseBausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
2024-04-02 08:04U:BHCNews ReleaseBased on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
2024-03-06 08:03U:BHCNews ReleaseSalix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
2024-03-05 08:03U:BHCNews ReleaseNew Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
2024-03-01 08:04U:BHCNews ReleaseBausch Health Companies to Present at Cowen Annual Health Care Conference
2024-02-22 07:06U:BHCNews ReleaseBausch Health Announces Fourth-Quarter and Full-Year 2023 Results
2024-02-12 08:04U:BHCNews ReleaseSalix Announces 2024 Gastrointestinal Health Scholars Program
2024-02-01 16:13U:BHCNews ReleaseBausch Health Announces Board Refreshment
2024-02-01 08:01U:BHCNews ReleaseBausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
2024-01-30 08:04U:BHCNews ReleaseCABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
2024-01-18 16:51U:BHCNews ReleaseCORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
2024-01-18 08:03U:BHCNews ReleaseSolta Medical ¢ € ™s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
2024-01-08 11:17U:BHCNews ReleaseCourt of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
2023-12-21 07:02U:BHCNews ReleaseBausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
2023-12-18 08:02U:BHCNews ReleaseDUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec ¢ € ™s Public Drug Plan